The EGFR is, therefore, a prime target for new anticancer therapy in SCCHN.The present invention relates to compounds capable of inhibiting the activity of SHP2. The invention further provides a process for the preparation of compounds of the invention and pharmaceutical preparations comprising such ...
High Purity N, N-Carbonyl Diimidazole CAS 530-62-1 Carbonyldiimidazole US$7.00-8.00 / kg EMI24 Curing Agent 99%Min 2-Ethyl-4-Methylimidazole CAS 931-36-2 US$2.00-4.00 / kg 1-Ethylimidazole CAS 7098-07-9 US$2.00-8.00 / kg 1-Ethyl-3-Methylimidazolium Chlroide...
High Purity N, N-Carbonyl Diimidazole CAS 530-62-1 Carbonyldiimidazole US$7.00-8.00 / kg EMI24 Curing Agent 99%Min 2-Ethyl-4-Methylimidazole CAS 931-36-2 US$2.00-4.00 / kg 1-Ethylimidazole CAS 7098-07-9 US$2.00-8.00 /...